JP2024517738A5 - - Google Patents
Info
- Publication number
- JP2024517738A5 JP2024517738A5 JP2023566493A JP2023566493A JP2024517738A5 JP 2024517738 A5 JP2024517738 A5 JP 2024517738A5 JP 2023566493 A JP2023566493 A JP 2023566493A JP 2023566493 A JP2023566493 A JP 2023566493A JP 2024517738 A5 JP2024517738 A5 JP 2024517738A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- minutes
- dmt
- approximately
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163179679P | 2021-04-26 | 2021-04-26 | |
| US63/179,679 | 2021-04-26 | ||
| PCT/US2022/026396 WO2022232179A1 (en) | 2021-04-26 | 2022-04-26 | Novel n,n-dimethyltryptamine compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517738A JP2024517738A (ja) | 2024-04-23 |
| JP2024517738A5 true JP2024517738A5 (cg-RX-API-DMAC7.html) | 2025-05-07 |
Family
ID=83694712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566493A Pending JP2024517738A (ja) | 2021-04-26 | 2022-04-26 | 新規のn,n-ジメチルトリプタミン組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11602521B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4329879A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024517738A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240000516A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117320711A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022267240A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023022195A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216889A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2023003191A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308074A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023012651A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022232179A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3753923A1 (en) | 2019-06-19 | 2020-12-23 | GH Research Limited | Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) in methyl tert.-butyl ether (mtbe) without adding an anti-solvent |
| EP3868364A1 (en) | 2020-02-24 | 2021-08-25 | GH Research Limited | Aerosol comprising 5-methoxy-n,n-dimethyltryptamine |
| IL297861A (en) | 2020-05-08 | 2023-01-01 | Psilera Inc | Novel compositions of matter and pharmaceutical compositions |
| KR20240013170A (ko) | 2021-05-25 | 2024-01-30 | 아타이 테라퓨틱스, 인크. | 신규 n,n-디메틸트립타민 염 및 결정질 염 형태 |
| IL309210A (en) | 2021-06-09 | 2024-02-01 | Atai Therapeutics Inc | Parent drugs and conjugates of dimethyltryptamine |
| CA3238440A1 (en) | 2021-12-30 | 2023-07-06 | Atai Therapeutics, Inc. | Dimethyltryptamine analogues as nitric oxide delivery drugs |
| KR20250005182A (ko) * | 2022-03-27 | 2025-01-09 | 지에이치 리서치 아일랜드 리미티드 | 인지기능 장애 치료를 위한 5-메톡시-n,n-다이메틸트립타민 |
| EP4608395A2 (en) * | 2022-10-26 | 2025-09-03 | ATAI Therapeutics, Inc. | N-n-dimethyltryptamine (dmt) and dmt analog compositions, methods of making, and methods of use thereof |
| DK202330319A1 (en) * | 2023-11-07 | 2025-05-27 | Fertin Pharma As | An adhesive oral disc for sustained release of cannabinoids |
| US20240325351A1 (en) | 2023-03-31 | 2024-10-03 | Cybin UK Ltd. | Method of administration |
| EP4773958A1 (en) * | 2023-09-08 | 2026-07-15 | ATAI Therapeutics, Inc. | Parenteral formulations for n,n-dimethyltryptamine (dmt) and dmt analogs, methods of making, and methods of use thereof |
| EP4788322A1 (en) * | 2023-10-02 | 2026-08-12 | ATAI Therapeutics, Inc. | N-n-dimethyltryptamine (dmt) and dmt analog oral transmucosal film compositions, methods of making, and methods of use thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60215685A (ja) * | 1984-04-11 | 1985-10-29 | Takeda Chem Ind Ltd | 2’−デオキシアリステロマイシン誘導体およびその用途 |
| US20220079881A1 (en) | 2016-03-03 | 2022-03-17 | Ctt Pharma Inc. | Orally Administrable Composition |
| US11723894B2 (en) * | 2017-10-26 | 2023-08-15 | Terran Biosciences, Inc. | Combination product for the treatment of neurological and/or psychiatric disorders |
| DK3927338T3 (da) * | 2019-02-22 | 2025-01-06 | Gh Res Ireland Limited | Sammensætninger omfattende 5-methoxy-n,n-dimethyltryptamin (5-meo-dmt) til anvendelse i behandling af mentale lidelser |
| HUE066828T2 (hu) | 2019-02-22 | 2024-09-28 | Gh Res Ireland Limited | 5-Metoxi-N,N-Dimetiltriptamin (5-Meo-Dmt) súlyos depressziós rendellenesség kezelésére |
| KR102946120B1 (ko) * | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| WO2020176597A1 (en) * | 2019-02-27 | 2020-09-03 | The Regents Of The University Of California | N-substituted indoles and other heterocycles for treating brain disorders |
| GB201907871D0 (en) * | 2019-06-03 | 2019-07-17 | Small Pharma Ltd | Therapeutic compositions |
| WO2021003467A1 (en) * | 2019-07-04 | 2021-01-07 | Sw Holdings, Inc. | Metered dosing compositions and methods of use of psychedelic compounds |
| US20210015738A1 (en) * | 2019-07-17 | 2021-01-21 | Concept Matrix Solutions | Oral dissolvable film containing psychedelic compound |
| US20210023052A1 (en) * | 2019-07-23 | 2021-01-28 | Caamtech Llc | Compositions containing toad secretion compounds |
| WO2021041407A1 (en) * | 2019-08-25 | 2021-03-04 | Caamtech Llc | Alkyl quarternary ammonium tryptamines and their therapeutic uses |
| CN115297851A (zh) * | 2019-12-31 | 2022-11-04 | Tf科技企业 | 口溶膜及其生产和使用方法 |
| IL297861A (en) | 2020-05-08 | 2023-01-01 | Psilera Inc | Novel compositions of matter and pharmaceutical compositions |
| US12042564B2 (en) | 2020-06-02 | 2024-07-23 | Cybin Uk Ltd | Therapeutic solid dosage forms |
| EP4167992A1 (en) * | 2020-06-22 | 2023-04-26 | University of Zürich | Compositions and kits of parts comprising n,n-dimethyltryptamine and harmine and their use in therapy |
| CA3188263A1 (en) * | 2020-08-05 | 2022-02-10 | Matthias Emanuel LIECHTI | Intravenous dmt administration method for dmt-assisted psychotherapy |
| CA3192617A1 (en) | 2020-09-20 | 2022-03-24 | Matthew BAGGOTT | Advantageous tryptamine compositions for mental disorders or enhancement |
| KR20240013170A (ko) * | 2021-05-25 | 2024-01-30 | 아타이 테라퓨틱스, 인크. | 신규 n,n-디메틸트립타민 염 및 결정질 염 형태 |
-
2022
- 2022-04-26 CA CA3216889A patent/CA3216889A1/en active Pending
- 2022-04-26 JP JP2023566493A patent/JP2024517738A/ja active Pending
- 2022-04-26 KR KR1020237038175A patent/KR20240000516A/ko active Pending
- 2022-04-26 MX MX2023012651A patent/MX2023012651A/es unknown
- 2022-04-26 US US17/730,013 patent/US11602521B2/en active Active
- 2022-04-26 CN CN202280031363.4A patent/CN117320711A/zh active Pending
- 2022-04-26 EP EP22796577.9A patent/EP4329879A4/en active Pending
- 2022-04-26 WO PCT/US2022/026396 patent/WO2022232179A1/en not_active Ceased
- 2022-04-26 AU AU2022267240A patent/AU2022267240A1/en active Pending
- 2022-04-26 BR BR112023022195A patent/BR112023022195A2/pt unknown
- 2022-04-26 IL IL308074A patent/IL308074A/en unknown
-
2023
- 2023-10-25 CL CL2023003191A patent/CL2023003191A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025142338A5 (cg-RX-API-DMAC7.html) | ||
| BRPI0711168A2 (pt) | composição transmucosal | |
| CZ20013344A3 (cs) | Farmaceutický prostředek vhodný pro léčení erektilní dysfunkce | |
| JP2023076465A5 (cg-RX-API-DMAC7.html) | ||
| JP2013501718A5 (cg-RX-API-DMAC7.html) | ||
| US20210308040A1 (en) | Ketamine oral transmucosal delivery system | |
| JP2010504312A (ja) | 活性成分の経粘膜投与のためのガレノス的方式 | |
| JP4597273B2 (ja) | 経口組成物 | |
| CN101505724A (zh) | 阿利吉仑的盖伦制剂 | |
| ES2324769T3 (es) | Comprimido que comprende cetrizina y pseudoefedrina. | |
| JP2023506545A (ja) | アゴメラチンを含有する経粘膜治療システム | |
| WO2018236678A1 (en) | Orally dissolving melatonin formulation with acidifying agent that renders melatonin soluble in saliva | |
| Sheoran | Buccal drug delivery system: A review | |
| CN101460144A (zh) | AchE-NMDA组合物干胶片 | |
| CN113597303B (zh) | 含有阿戈美拉汀的经粘膜治疗系统 | |
| JP2025539650A (ja) | レミマゾラムを含有する口腔粘膜送達システム | |
| KR100708560B1 (ko) | 미르타자핀을 포함한 경구 붕해성 조성물 | |
| CN100418526C (zh) | 依贝沙坦在制备用来预防或治疗肺动脉高压的药物中的应用 | |
| ES2459203T3 (es) | Tratamiento de combinación con fármacos | |
| ES2309357T3 (es) | Nueva combinacion sinergica que comprende roflumilast y formoterol. | |
| US11583518B2 (en) | Non-hormonal compositions and methods for male contraception | |
| JP2007512270A (ja) | デオキシペガニンの経口製剤およびそれらの使用 | |
| CN107249595A (zh) | 灌肠剂 | |
| WO2006013914A1 (ja) | 口腔粘膜投与剤 | |
| JP2006070027A (ja) | 口腔粘膜投与剤 |